1592 related articles for article (PubMed ID: 30141353)
21. Design, synthesis and biological evaluation of 3-substituted-2-oxindole hybrid derivatives as novel anticancer agents.
Romagnoli R; Baraldi PG; Prencipe F; Oliva P; Baraldi S; Salvador MK; Lopez-Cara LC; Bortolozzi R; Mattiuzzo E; Basso G; Viola G
Eur J Med Chem; 2017 Jul; 134():258-270. PubMed ID: 28419928
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners.
Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T
Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378
[TBL] [Abstract][Full Text] [Related]
23. Design, Synthesis and Molecular Docking Studies of Novel Indole-Pyrimidine Hybrids as Tubulin Polymerization Inhibitors.
Hu MJ; Zhang B; Yang HK; Liu Y; Chen YR; Ma TZ; Lu L; You WW; Zhao PL
Chem Biol Drug Des; 2015 Dec; 86(6):1491-500. PubMed ID: 26177395
[TBL] [Abstract][Full Text] [Related]
24. Some new indole-coumarin hybrids; Synthesis, anticancer and Bcl-2 docking studies.
Kamath PR; Sunil D; Ajees AA; Pai KS; Das S
Bioorg Chem; 2015 Dec; 63():101-9. PubMed ID: 26469742
[TBL] [Abstract][Full Text] [Related]
25. Design, synthesis, antiproliferative activity and docking studies of quinazoline derivatives bearing 2,3-dihydro-indole or 1,2,3,4-tetrahydroquinoline as potential EGFR inhibitors.
OuYang Y; Zou W; Peng L; Yang Z; Tang Q; Chen M; Jia S; Zhang H; Lan Z; Zheng P; Zhu W
Eur J Med Chem; 2018 Jun; 154():29-43. PubMed ID: 29775935
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and Biological Evaluation of 1-Methyl-1H-indole-Pyrazoline Hybrids as Potential Tubulin Polymerization Inhibitors.
Zhang YL; Qin YJ; Tang DJ; Yang MR; Li BY; Wang YT; Cai HY; Wang BZ; Zhu HL
ChemMedChem; 2016 Jul; 11(13):1446-58. PubMed ID: 27159418
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis and biological evaluation of novel pyrenyl derivatives as anticancer agents.
Bandyopadhyay D; Sanchez JL; Guerrero AM; Chang FM; Granados JC; Short JD; Banik BK
Eur J Med Chem; 2015 Jan; 89():851-62. PubMed ID: 25462285
[TBL] [Abstract][Full Text] [Related]
28. Synthesis, structure-activity relationship studies and biological evaluation of novel 2,5-disubstituted indole derivatives as anticancer agents.
Hu H; Wu J; Ao M; Wang H; Zhou T; Xue Y; Qiu Y; Fang M; Wu Z
Chem Biol Drug Des; 2016 Nov; 88(5):766-778. PubMed ID: 27315790
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and antiproliferative activity of conformationally restricted 1,2,3-triazole analogues of combretastatins in the sea urchin embryo model and against human cancer cell lines.
Demchuk DV; Samet AV; Chernysheva NB; Ushkarov VI; Stashina GA; Konyushkin LD; Raihstat MM; Firgang SI; Philchenkov AA; Zavelevich MP; Kuiava LM; Chekhun VF; Blokhin DY; Kiselyov AS; Semenova MN; Semenov VV
Bioorg Med Chem; 2014 Jan; 22(2):738-55. PubMed ID: 24387982
[TBL] [Abstract][Full Text] [Related]
30. Structure-activity relationship studies of 3-aroylindoles as potent antimitotic agents.
Liou JP; Mahindroo N; Chang CW; Guo FM; Lee SW; Tan UK; Yeh TK; Kuo CC; Chang YW; Lu PH; Tung YS; Lin KT; Chang JY; Hsieh HP
ChemMedChem; 2006 Oct; 1(10):1106-18. PubMed ID: 16952120
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis and biological evaluation of N-alkyl or aryl substituted isoindigo derivatives as potential dual cyclin-dependent kinase 2 (CDK2)/glycogen synthase kinase 3β (GSK-3β) phosphorylation inhibitors.
Zhao P; Li Y; Gao G; Wang S; Yan Y; Zhan X; Liu Z; Mao Z; Chen S; Wang L
Eur J Med Chem; 2014 Oct; 86():165-74. PubMed ID: 25151579
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents.
Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA
Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, Anticancer Activity and Molecular Modeling Studies of Novel Chalcone Derivatives Containing Indole and Naphthalene Moieties as Tubulin Polymerization Inhibitors.
Wang G; Peng Z; Li Y
Chem Pharm Bull (Tokyo); 2019 Jul; 67(7):725-728. PubMed ID: 30982797
[TBL] [Abstract][Full Text] [Related]
34. Discovery of novel 4(1H)-quinolone derivatives as potential antiproliferative and apoptosis inducing agents.
Zhou P; Huang L; Zhou J; Jiang B; Zhao Y; Deng X; Zhao Q; Li F
Bioorg Med Chem Lett; 2017 Sep; 27(17):4185-4189. PubMed ID: 28757067
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and antiproliferative and apoptosis-inducing activity of novel 3-substituted-3-hydroxy-2-oxindole compounds.
Nazemi Moghaddam M; Jalal R; Zeraatkar Z
In Vitro Cell Dev Biol Anim; 2018 Jan; 54(1):61-70. PubMed ID: 29124512
[TBL] [Abstract][Full Text] [Related]
36. The Effects of 1,3,5-trisubstituted Indole Derivatives on Cell Growth, Apoptosis and MMP-2/9 mRNA Expression of MCF-7 Human Breast Cancer Cells.
Bakar F; Kilic-Kurt Z; Caglayan MG; Olgen S
Anticancer Agents Med Chem; 2017; 17(5):762-767. PubMed ID: 27491936
[TBL] [Abstract][Full Text] [Related]
37. Synthesis, Evaluation, and Mechanism Study of Novel Indole-Chalcone Derivatives Exerting Effective Antitumor Activity Through Microtubule Destabilization in Vitro and in Vivo.
Yan J; Chen J; Zhang S; Hu J; Huang L; Li X
J Med Chem; 2016 Jun; 59(11):5264-83. PubMed ID: 27149641
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, biological evaluation and molecular docking studies of trans-indole-3-acrylamide derivatives, a new class of tubulin polymerization inhibitors.
Baytas SN; Inceler N; Yilmaz A; Olgac A; Menevse S; Banoglu E; Hamel E; Bortolozzi R; Viola G
Bioorg Med Chem; 2014 Jun; 22(12):3096-104. PubMed ID: 24816066
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and biological evaluation of novel non-racemic indole-containing allocolchicinoids.
Shchegravina ES; Maleev AA; Ignatov SK; Gracheva IA; Stein A; Schmalz HG; Gavryushin AE; Zubareva AA; Svirshchevskaya EV; Fedorov AY
Eur J Med Chem; 2017 Dec; 141():51-60. PubMed ID: 29028531
[TBL] [Abstract][Full Text] [Related]
40. Substitution at the indole 3 position yields highly potent indolecombretastatins against human tumor cells.
Álvarez R; Gajate C; Puebla P; Mollinedo F; Medarde M; Peláez R
Eur J Med Chem; 2018 Oct; 158():167-183. PubMed ID: 30216850
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
